50 gloves per box
10 boxes per carton
Buy direct from Mun
GloveOn Matador is built with quality, consistency and reliability in an 8ml nitrile glove. With GloveOn Matador, users can take confidence in wearing a stronger glove to shape their performance in their work duties.
Features
| Reorder code | Size |
|---|---|
| NTR18SS | Small |
| MTR151MM | Medium |
| NTR18LL | Large |
| MTR151XL | X-Large |
| International Standards | |
|---|---|
| Standards | AS/NZS 4011-1 ASTM D6319 ASTM D5151 ASTM D6124 ASTM D6978 EN 420 EN 16523-1 EN ISO 374-1 (Type A) EN 374 part 2, 4 & 5 ISO 11193-1 EN 455 part 1, 2, 3 & 4 ISO 10993 part 5 & 10 HACCP International Certified |
| Manufacturing Accreditations | |
|---|---|
| Accreditations | ISO 9001 ISO 13485 |
| EN ISO 374-1:2016 Type A | Permeation Performance Level |
|---|---|
| Sulphuric Acid 96% (L) | 2 |
| n-Heptane (J) | 3 |
| Sodium Hydroxide 40% (K) | 6 |
| Ammonium hydroxide 25% (O) | 4 |
| Formaldehyde 37% (T) | 6 |
| Hydrogen peroxide 30% (P) | 6 |
| Hydrofluoric acid 40% (S) | 2 |
| Chemotherapy Drugs and Concentration (Tested for Resistance to Permeation by Chemotherapy Drugs as per ASTM D6978-05, Test Report PN 107200B) | Minimum Breakthrough Detection Time (minutes) |
|---|---|
| Carmustine (BCNU), 3.3mg/ml (3,300ppm) | 90.6 |
| Cisplatin, 1.0mg/ml (1,000ppm) | >240 |
| Cyclophosphamide (Cytoxan), 20.0mg/ml (20,000ppm) | >240 |
| Dacarbazine (DTIC), 10.0mg/ml (10,000ppm) | >240 |
| Doxorubicin Hydrochloride, 2.0mg/ml (2,000ppm) | >240 |
| Etoposide (Toposar), 20.0mg/ml (20,000ppm) | >240 |
| Fluorouracil, 50.0mg/ml (50,000ppm) | >240 |
| Methotrexate, 25.0mg/ml (25,000ppm) | >240 |
| Mitomycin C, 0.5mg/ml (500ppm) | >240 |
| Paclitaxel (Taxol), 6.0mg/ml (6,000ppm) | >240 |
| Thiotepa, 10.0mg/ml (10,000ppm) | 165.8 |
| Vincristine Sulfate, 1.0mg/ml (1,000ppm) | >240 |
| WARNING: Carmustine and Thiotepa, at the tested concentration, degraded Matador nitrile glove at 90.6 minutes and 165.8 minutes respectively. The safe use of gloves in chemotherapy treatment is solely the decision of clinicians authorised to make such a decision. | |
| Glove Properties | Measurement (mm) |
|---|---|
| Length | ≥230 |
| Thickness at Palm (centre of Palm) | ≥0.08 |
| Thickness at Finger (13mm ± 3mm from tip) | ≥0.11 |
| Physical Properties | Before Ageing | After Ageing |
|---|---|---|
| Tensile Strength (MPa) | ≥18 | ≥16 |
| Elongation (%) | ≥500 | ≥400 |
| Inspection Levels and AQL | Inspection Level | AQL |
|---|---|---|
| Watertightness | G1 | 1.5 |
| Physical Dimensions | S2 | 4.0 |
| Tensile Strength | S2 | 4.0 |
| Visual Inspection (Major) | S4 | 2.5 |
| Visual Inspection (Minor) | S4 | 4.0 |
| Particulate Residue | N=5 | ≤2mg/glove |
| Regulatory Compliance | |
|---|---|
| Regulations | ARTG 164563 MDD 93/42/EEC REACH ROHS Directive 2002/95/EC EU 10/2011 EC 1935/2004 EU 2016/425 |
| Packaging | |
|---|---|
| Configuration | 200 gloves per box for XS to L 180 gloves per box for XL 10 boxes per carton |
| Reorder code | Size |
|---|---|
| NTR18SS | Small |
| MTR151MM | Medium |
| NTR18LL | Large |
| MTR151XL | X-Large |
| International Standards | |
|---|---|
| Standards | AS/NZS 4011-1 ASTM D6319 ASTM D5151 ASTM D6124 ASTM D6978 EN 420 EN 16523-1 EN ISO 374-1 (Type A) EN 374 part 2, 4 & 5 ISO 11193-1 EN 455 part 1, 2, 3 & 4 ISO 10993 part 5 & 10 HACCP International Certified |
| Manufacturing Accreditations | |
|---|---|
| Accreditations | ISO 9001 ISO 13485 |
| EN ISO 374-1:2016 Type A | Permeation Performance Level |
|---|---|
| Sulphuric Acid 96% (L) | 2 |
| n-Heptane (J) | 3 |
| Sodium Hydroxide 40% (K) | 6 |
| Ammonium hydroxide 25% (O) | 4 |
| Formaldehyde 37% (T) | 6 |
| Hydrogen peroxide 30% (P) | 6 |
| Hydrofluoric acid 40% (S) | 2 |
| Chemotherapy Drugs and Concentration (Tested for Resistance to Permeation by Chemotherapy Drugs as per ASTM D6978-05, Test Report PN 107200B) | Minimum Breakthrough Detection Time (minutes) |
|---|---|
| Carmustine (BCNU), 3.3mg/ml (3,300ppm) | 90.6 |
| Cisplatin, 1.0mg/ml (1,000ppm) | >240 |
| Cyclophosphamide (Cytoxan), 20.0mg/ml (20,000ppm) | >240 |
| Dacarbazine (DTIC), 10.0mg/ml (10,000ppm) | >240 |
| Doxorubicin Hydrochloride, 2.0mg/ml (2,000ppm) | >240 |
| Etoposide (Toposar), 20.0mg/ml (20,000ppm) | >240 |
| Fluorouracil, 50.0mg/ml (50,000ppm) | >240 |
| Methotrexate, 25.0mg/ml (25,000ppm) | >240 |
| Mitomycin C, 0.5mg/ml (500ppm) | >240 |
| Paclitaxel (Taxol), 6.0mg/ml (6,000ppm) | >240 |
| Thiotepa, 10.0mg/ml (10,000ppm) | 165.8 |
| Vincristine Sulfate, 1.0mg/ml (1,000ppm) | >240 |
| WARNING: Carmustine and Thiotepa, at the tested concentration, degraded Matador nitrile glove at 90.6 minutes and 165.8 minutes respectively. The safe use of gloves in chemotherapy treatment is solely the decision of clinicians authorised to make such a decision. | |
| Glove Properties | Measurement (mm) |
|---|---|
| Length | ≥230 |
| Thickness at Palm (centre of Palm) | ≥0.08 |
| Thickness at Finger (13mm ± 3mm from tip) | ≥0.11 |
| Physical Properties | Before Ageing | After Ageing |
|---|---|---|
| Tensile Strength (MPa) | ≥18 | ≥16 |
| Elongation (%) | ≥500 | ≥400 |
| Inspection Levels and AQL | Inspection Level | AQL |
|---|---|---|
| Watertightness | G1 | 1.5 |
| Physical Dimensions | S2 | 4.0 |
| Tensile Strength | S2 | 4.0 |
| Visual Inspection (Major) | S4 | 2.5 |
| Visual Inspection (Minor) | S4 | 4.0 |
| Particulate Residue | N=5 | ≤2mg/glove |
| Regulatory Compliance | |
|---|---|
| Regulations | ARTG 164563 MDD 93/42/EEC REACH ROHS Directive 2002/95/EC EU 10/2011 EC 1935/2004 EU 2016/425 |
| Packaging | |
|---|---|
| Configuration | 200 gloves per box for XS to L 180 gloves per box for XL 10 boxes per carton |
